Current Report Filing (8-k)
06 Setembro 2013 - 6:12PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) September 5, 2013
HEALTHIENT, INC.
(exact name of registrant as specified in its charter)
Nevada
(State or other jurisdiction of incorporation)
333-59114
|
33-0730042
|
Commission File Number
|
IRS Employer Identification Number
|
15132 Park of Commerce Blvd., 2nd Floor, FL
|
33478
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant's telephone number, including area code: (888) 720 2112
TIME ASSOCIATES, INC.
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (SEE General Instruction A.2. below):
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
The majority shareholders of Healthient, Inc., a Nevada corporation
(the "Registrant") constituting a total of 24,892,164 shares (60.04%) approved as of September 5, 2013, in a written consent of
the majority of the shareholders of the Registrant the following corporate actions of the Registrant: a name change from its current
name to "SnackHealthy, Inc." and a 1-for-100 reverse stock split of the Registrant's outstanding common stock. The Registrant
believes that its new name will better reflect the Registrant's focus on consumer business. The Registrant's new public company
name will now align with the name of the Registrant's products. With this change, the Registrant believes that
consumers, partners and shareholders will view the products as synonymous with the Company. As of the record
date determined by the Registrant's Board of Directors, the presently issued and outstanding shares of common stock of the Registrant
will be converted and changed to shares of common stock of the Registrant at a ratio of one hundred (100) pre-split shares of
common stock to be converted to one (1) post-split share of common stock of the Registrant. Following the required regulatory
approval and the filing of the amended articles of incorporation of the Registrant, the Registrant will announce the effective
date of the name change and the reverse stock split.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act or 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
HEALTHIENT, INC.
|
|
|
|
|
|
|
By:
|
/s/ Katherine T. West |
|
|
|
Katherine T. West
|
|
|
|
President
|
|
|
|
|
|
Curative Biosciences (CE) (USOTC:CBDX)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Curative Biosciences (CE) (USOTC:CBDX)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
Notícias em tempo-real sobre Curative Biosciences Inc (CE) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de Healthient, Inc.